Compare Humana Inc (HUM) vs Kinder Morgan Inc (KMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Kinder Morgan Inc — how do they compare? Humana Inc trades at $373.38 (market cap $46.31B), while Kinder Morgan Inc trades at $31.5 (market cap $69.90B). The key difference: Kinder Morgan Inc is the larger of the two by market cap, and Kinder Morgan Inc pays the higher dividend (3.76%). Which is the better fit depends on your goals.
| HUM | KMI | |
|---|---|---|
Market Cap | $46.31B | $69.90B |
Sector | Health | Energy |
52-Week High | $409.42 | $34.31 |
52-Week Low | $163.67 | $25.84 |
Enterprise Value | $53.67B | $101.95B |
Dividend Yield | 0.92% | 3.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
Kinder Morgan (KMI) trades at $30.85, down 1.37% over the past day, with a bearish technical signal from moving averages and oscillators. The company reported strong Q2 2026 earnings, beating estimates with EPS of $0.37 versus $0.32 expected, and raised full-year guidance. Revenue for 2025 was $16.94 billion, with net income of $3.06 billion and a profit margin of 18.04%. Recent news highlights growth in natural gas infrastructure driven by LNG and power demand, supporting a dividend of $0.30 per share.
KMI presents a mixed outlook; fundamentals are solid with earnings beats and a robust project pipeline, but technical indicators signal near-term caution. Investment opportunities include dividend income and exposure to energy infrastructure growth, while risks involve debt levels and oil price volatility. Analyst consensus is nearly evenly split between buy and hold ratings, reflecting balanced sentiment amid macroeconomic uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →
